Investment House LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434K Sell
18,005
-1,798
-9% -$47K 0.02% 183
2026
Q1
$556K Sell
19,803
-250
-1% -$6.66K 0.03% 169
2025
Q4
$499K Buy
20,053
+5
+0% +$126 0.02% 171
2025
Q3
$511K Sell
20,048
-1,143
-5% -$28.2K 0.02% 183
2025
Q2
$514K Buy
21,191
+993
+5% +$23.2K 0.03% 177
2025
Q1
$512K Buy
20,198
+500
+3% +$13.1K 0.03% 174
2024
Q4
$523K Sell
19,698
-4,075
-17% -$111K 0.03% 160
2024
Q3
$688K Sell
23,773
-1,532
-6% -$44.7K 0.04% 159
2024
Q2
$708K Sell
25,305
-575
-2% -$15.8K 0.04% 145
2024
Q1
$718K Sell
25,880
-950
-4% -$26.4K 0.04% 143
2023
Q4
$772K Sell
26,830
-2,372
-8% -$71.7K 0.05% 130
2023
Q3
$969K Sell
29,202
-6,161
-17% -$218K 0.08% 119
2023
Q2
$1.3M Sell
35,363
-24,378
-41% -$949K 0.1% 110
2023
Q1
$2.44M Sell
59,741
-350
-0.6% -$15.1K 0.2% 85
2022
Q4
$3.08M Sell
60,091
-2,550
-4% -$122K 0.29% 74
2022
Q3
$2.74M Buy
62,641
+623
+1% +$30.3K 0.26% 72
2022
Q2
$3.25M Sell
62,018
-1,625
-3% -$82.8K 0.29% 71
2022
Q1
$3.29M Sell
63,643
-7,200
-10% -$374K 0.24% 74
2021
Q4
$4.18M Sell
70,843
-2,000
-3% -$99.1K 0.27% 69
2021
Q3
$3.13M Sell
72,843
-300
-0.4% -$13.3K 0.23% 73
2021
Q2
$2.86M Buy
73,143
+9,400
+15% +$366K 0.2% 81
2021
Q1
$2.31M Sell
63,743
-625
-1% -$22.2K 0.18% 82
2020
Q4
$2.37M Sell
64,368
-3,002
-4% -$110K 0.17% 90
2020
Q3
$2.35M Sell
67,370
-1,317
-2% -$46.2K 0.18% 83
2020
Q2
$2.13M Buy
68,687
+864
+1% +$29.4K 0.19% 85
2020
Q1
$2.1M Sell
67,823
-1,976
-3% -$67.3K 0.24% 81
2019
Q4
$2.6M Sell
69,799
-4,400
-6% -$157K 0.24% 81
2019
Q3
$2.53M Sell
74,199
-1,265
-2% -$46K 0.26% 83
2019
Q2
$3.1M Sell
75,464
-47
-0.1% -$1.87K 0.32% 72
2019
Q1
$3.04M Sell
75,511
-737
-1% -$29.5K 0.33% 72
2018
Q4
$3.16M Sell
76,248
-2,391
-3% -$99.3K 0.39% 70
2018
Q3
$3.29M Sell
78,639
-2,311
-3% -$89K 0.35% 74
2018
Q2
$2.79M Sell
80,950
-2,099
-3% -$71.7K 0.32% 75
2018
Q1
$2.8M Sell
83,049
-3,551
-4% -$122K 0.34% 75
2017
Q4
$2.98M Sell
86,600
-4,706
-5% -$160K 0.36% 74
2017
Q3
$3.09M Sell
91,306
-12,337
-12% -$397K 0.4% 70
2017
Q2
$3.3M Sell
103,643
-1,391
-1% -$43.9K 0.44% 66
2017
Q1
$3.41M Sell
105,034
-1,921
-2% -$60.6K 0.48% 66
2016
Q4
$3.3M Sell
106,955
-204
-0.2% -$6.23K 0.5% 66
2016
Q3
$3.44M Sell
107,159
-1,313
-1% -$43.9K 0.52% 64
2016
Q2
$3.62M Sell
108,472
-294
-0.3% -$9.38K 0.58% 62
2016
Q1
$3.06M Buy
108,766
+5,465
+5% +$156K 0.49% 69
2015
Q4
$3.16M Buy
103,301
+23,562
+30% +$741K 0.52% 66
2015
Q3
$2.38M Sell
79,739
-100
-0.1% -$3.21K 0.41% 77
2015
Q2
$2.54M Sell
79,839
-270
-0.3% -$8.8K 0.41% 78
2015
Q1
$2.64M Sell
80,109
-270
-0.3% -$8.58K 0.43% 75
2014
Q4
$2.38M Sell
80,379
-1,946
-2% -$55.8K 0.38% 77
2014
Q3
$2.31M Sell
82,325
-238
-0.3% -$6.68K 0.38% 75
2014
Q2
$2.33M Sell
82,563
-417
-0.5% -$11.9K 0.4% 76
2014
Q1
$2.53M Buy
82,980
+7,603
+10% +$227K 0.45% 72
2013
Q4
$2.19M Sell
75,377
-44,649
-37% -$1.3M 0.4% 73
2013
Q3
$3.27M Buy
120,026
+4
+0% +$109 0.66% 56
2013
Q2
$3.19M Buy
+120,022
New +$3.32M 0.69% 49

Other funds holding PFE

Investment House LLC's PFE Position: Q2 2026 in Review

Investment House LLC reduced its Pfizer (PFE) stake by 9.1% in Q2 2026, selling an estimated $47K and leaving 18,005 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #183.

Investment House LLC first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.18M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Investment House LLC held 18,005 shares of Pfizer worth $434K as of Q2 2026.
  • Investment House LLC sold 1,798 Pfizer shares in Q2 2026, an estimated $47K.
  • Pfizer made up 0.02% of Investment House LLC's portfolio in Q2 2026, its #183 holding.
  • Investment House LLC first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Investment House LLC's Pfizer position peaked at $4.18M in Q4 2021.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.